Novotech Announces Expansion into Taiwan
Increasing demand for quality research has prompted the opening of a Novotech dedicated office to manage global and regional studies. The Taipei office will complement existing operations in India, South Korea, Thailand, Malaysia and Singapore.
Novotech CEO Alek Safarian said at Partnerships in Clinical Trials Phoenix, Arizona) that the first Taipei office employee was hired this month and five more will be in place by mid-year.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025